Cargando…
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
The tumor microenvironment (TME) is a hypoxic, acidic, and immune/inflammatory cell–enriched milieu that plays crucial roles in tumor development, growth, progression, and therapy resistance. Targeting TME is an attractive strategy for the treatment of solid tumors. Conventional cancer chemotherapie...
Autores principales: | Zhong, Shangwei, Jeong, Ji-Hak, Chen, Zhikang, Chen, Zihua, Luo, Jun-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909103/ https://www.ncbi.nlm.nih.gov/pubmed/31785429 http://dx.doi.org/10.1016/j.tranon.2019.10.001 |
Ejemplares similares
-
Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer
por: Zhong, Shangwei, et al.
Publicado: (2022) -
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Zhong, Shangwei, et al.
Publicado: (2021) -
Small molecule inhibitors targeting the cancers
por: Liu, Gui‐Hong, et al.
Publicado: (2022) -
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
por: Osipov, Arsen, et al.
Publicado: (2019) -
Small-Molecule Targets in Tumor Immunotherapy
por: Zhu, Hui-Fang, et al.
Publicado: (2018)